Financial News Feed

Weaker Buy Today ALDR ranks #313 as BUY CANDIDATE. Stronger Buy
Today ALDR ranks #313 as BUY CANDIDATE.

ALDR stock Alder BioPharmaceuticals

ALDR stock
Alder BioPharmaceuticals

Tracking some short-term indicators on shares of Alder Biopharma (ALDR) we note that the current 7-day average directional indicator is Buy. This signal can be used to determine the market trend. The ...

Read more

Alder BioPharmaceuticals Inc. (ALDR) had a good day on the market for Friday January 18 as shares jumped 8.5% to close at $13.41. About 1.75 million shares traded hands on 8,186 trades for the...

Read more

Alder Biopharmaceuticals Inc (NASDAQ:ALDR) has received an average recommendation of “Buy” from the sixteen analysts that are presently covering the stock, MarketBeat Ratings reports. One research...

Read more

Shares of Alder Biopharma (ALDR) are being monitored closely as they have moved below the Elder Force zero line. Elder’s Force Index (or EFI) uses volume and price change from previous close to dete...

Read more

Alder BioPharmaceuticals Inc. (ALDR) had a good day on the market for Thursday January 17 as shares jumped 6.09% to close at $12.36. About 1.49 million shares traded hands on 7,685 trades for the...

Read more

Zacks Investment Research cut shares of Alder Biopharmaceuticals (NASDAQ:ALDR) from a buy rating to a hold rating in a research report sent to investors on Monday morning. According to Zacks, “Alder...

Read more

(RTTNews) - Today's Daily Dose brings you news about Alder Biopharma's after-hours stock movement; Mirati's stock offering; FDA panel recommendation of Amgen/UCB's osteoporosis drug Evenity; and Pain ...

Read more

(MENAFN - GlobeNewsWire - Nasdaq) itemprop="articleBody">BOTHELL, Wash., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical compan......

Read more

Investors may be taking a look at the longer term performance on shares of Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR). After a recent check, we have noted that the stock has lost -38.49% in the prev...

Read more

Investors may be looking at some various trading signals on shares of Alder Biopharma (ALDR). After a recent look, we noticed that the current 20-day moving average vs price signal is Buy. This is the...

Read more

Checking in on some valuation rankings, Alder Biopharmaceuticals, Inc. (NasdaqGM:ALDR) has a Value Composite score of 98. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. T...

Read more

Investors may be focusing on technical signals for Alder Biopharma (ALDR). Taking a look at the longer-term MACD oscillator indicator, we note that the reading is currently Sell. The MACD is generally...

Read more

Sell-side analysts are offering a consensus “Buy” rating on shares of Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR). Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell a...

Read more

Cactus, Inc. (NYSE:WHD) has a current MF Rank of 1082. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive...

Read more

The stock of Alder Biopharmaceuticals Inc (NASDAQ:ALDR) registered an increase of 5.61% in short interest. ALDR's total short interest was 12.17 million shares...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank